Decline in Serum Cholinesterase Activities Predicts 2-Year Major Adverse Cardiac Events
Yaron Arbel(Tel Aviv Sourasky Medical Center), Shmuel Banai(Tel Aviv Sourasky Medical Center), Amir Halkin(Tel Aviv University), Nir Waiskopf(Hebrew University of Jerusalem), Itzhak Shapira(Tel Aviv University), Shani Shenhar‐Tsarfaty(Tel Aviv University), Ariel Finkelstein, Gad Keren(Assuta Medical Center), Itzhak Herz(Tel Aviv University), Hermona Soreq(Hebrew University of Jerusalem), Shlomo Berliner(Tel Aviv University), Miri Revivo(Tel Aviv University)
Cited by 56
Related Papers
Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers
|Molecular Medicine|2000|1.5k
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|731
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|646
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
|Atherosclerosis|2012|390
Role of Naturally Occurring CD4 <sup>+</sup> CD25 <sup>+</sup> Regulatory T Cells in Experimental Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2007|347